Surgery to remove the pituitary tumor causing excess cortisol production is the primary treatment for Cushing’s disease, with long-term remission rates averaging 80% at experienced surgical centers. When surgery isn’t fully successful or the disease comes back, a combination of medications, radiation therapy, and in some cases removal of the adrenal glands can bring cortisol levels under control.
Pituitary Surgery Is the First Step
The standard operation for Cushing’s disease is a transsphenoidal adenomectomy, where a surgeon reaches the pituitary gland through the nose and sinuses to remove the cortisol-producing tumor. This avoids opening the skull entirely. For patients with small, well-defined tumors (microadenomas), long-term remission rates range from 86% to 98%. Larger tumors (macroadenomas) are harder to fully remove, with remission rates dropping to 31% to 83%. Tumors that have grown into surrounding tissue fare worst, with success rates between 22% and 65%.
If the surgeon can’t locate a distinct tumor during the operation, they may remove part or all of the pituitary gland itself. Across large patient series, this approach produces similar long-term remission rates to selective tumor removal. What matters most is having the surgery performed at a center with high-volume experience in pituitary operations.
After surgery, doctors check your morning cortisol level the next day. A reading below 5 micrograms per deciliter on the first postoperative morning is a strong predictor of lasting remission. Very low cortisol right after surgery is actually a good sign: it means the tumor tissue responsible for overproducing cortisol has been successfully removed, and your remaining pituitary and adrenal glands need time to “wake up.”
Recovery After Successful Surgery
Even when surgery works, recovery is a process that takes months. Your body has been flooded with excess cortisol, sometimes for years, and its cortisol-producing machinery essentially shuts down once the tumor is gone. This means you’ll need to take replacement steroid hormones (typically hydrocortisone) while your system recovers. Many centers start with higher-than-normal doses, taken two to three times daily, then gradually reduce the dose over two to four weeks.
During this tapering period, you may experience steroid withdrawal symptoms: fatigue, weakness, nausea, abdominal pain, lightheadedness, and low blood pressure. These symptoms can feel alarming, but they’re expected. The tricky part is that steroid withdrawal looks almost identical to a genuine adrenal crisis, where your body truly can’t produce enough cortisol on its own. Your medical team will monitor your cortisol levels closely to tell the difference and adjust your replacement dose accordingly. Full recovery of the body’s natural cortisol production can take anywhere from several months to over a year.
When the Disease Comes Back
Remission after surgery isn’t always permanent. Among patients who achieve initial remission, roughly 18% experience recurrence. A 2025 international study published in The Lancet Diabetes & Endocrinology found that the risk varies significantly based on tumor genetics and size. Patients with small tumors that don’t carry a specific gene variant (USP8) had a 10-year recurrence rate of about 15%. Larger tumors without the variant recurred at nearly 45% over the same period, and tumors carrying the USP8 variant fell in between at roughly 37%.
This means long-term follow-up is essential even after a successful operation. Regular cortisol testing, often for a decade or more, helps catch recurrence early when it’s easier to manage.
Medications to Lower Cortisol
Medications play a role before surgery (to reduce cortisol and improve surgical risk), after incomplete surgery, or when the disease recurs. Several drug classes work through different pathways.
Cortisol Synthesis Blockers
These drugs interfere with the enzymes your adrenal glands use to manufacture cortisol. Osilodrostat blocks the final step of cortisol production and is taken orally, usually starting at a low dose twice daily and adjusted every two weeks based on cortisol measurements. It’s one of the more recently approved options and gives doctors a targeted way to dial cortisol levels down gradually.
Ketoconazole, originally developed as an antifungal, also suppresses cortisol production and has been used off-label for Cushing’s disease for decades. Both drugs require careful dose adjustments because blocking too much cortisol can tip you into adrenal insufficiency.
Pituitary-Targeted Drugs
Since Cushing’s disease originates in the pituitary gland, some medications aim to shrink the tumor or reduce the hormonal signal that drives cortisol production. Pasireotide targets specific receptors on pituitary tumor cells. In a study of 68 patients, about half achieved normal cortisol levels by week 35, either on pasireotide alone or in combination with cabergoline (a drug that targets dopamine receptors on the tumor). However, among those who initially responded to combination therapy, roughly 62% eventually “escaped,” meaning their cortisol crept back up despite continued treatment. This highlights that medications often need to be adjusted or combined over time.
Cortisol Receptor Blockers
Rather than reducing how much cortisol your body makes, mifepristone blocks cortisol from acting on your tissues. It’s the only FDA-approved drug specifically for controlling high blood sugar caused by excess cortisol in Cushing’s syndrome. In clinical studies, 60% of patients with diabetes or glucose intolerance saw meaningful improvement in their blood sugar profiles, and 87% showed improved insulin sensitivity. Patients also experienced reductions in body weight, waist circumference, fat mass, fasting glucose, and blood pressure. Because mifepristone doesn’t lower cortisol itself (it blocks its effects), standard cortisol blood tests can’t be used to monitor the dose. Doctors rely on clinical improvements instead.
Radiation Therapy
When surgery doesn’t fully remove the tumor or isn’t an option, focused radiation (stereotactic radiosurgery) can target remaining pituitary tumor tissue with high precision. An international multicenter study found that the average time to cortisol normalization after radiation was about 14.5 months, so this is not a quick fix. Patients typically take cortisol-lowering medications in the interim to manage symptoms while waiting for radiation to take full effect.
The main long-term risk is damage to the surrounding healthy pituitary tissue. About 25% of patients develop new hormone deficiencies after radiation, most commonly an underactive thyroid (17% of cases). A small percentage (3%) experience cranial nerve issues. These side effects can develop years after treatment, which means ongoing hormone monitoring is necessary for life.
Bilateral Adrenalectomy as a Last Resort
If all other treatments fail, surgically removing both adrenal glands eliminates the body’s ability to produce cortisol entirely. This guarantees an end to hypercortisolism, but it comes with a significant trade-off: you’ll need to take both glucocorticoid and mineralocorticoid replacement hormones for the rest of your life, because your body can no longer make these essential hormones on its own. Missing doses can trigger a life-threatening adrenal crisis.
There’s also a specific risk called Nelson syndrome, where the original pituitary tumor grows aggressively after the adrenal glands are removed. Without the feedback signal from cortisol, the tumor loses its natural brake and can enlarge rapidly. This complication occurs in about 28% of patients who don’t receive preventive radiation therapy to the pituitary beforehand. For this reason, doctors often recommend pituitary radiation before or shortly after adrenalectomy to reduce the risk.